Indeed, it has been shown that MIF levels positively correlate with disease severity in COVID-19, reflecting the inability of patients to control the increased pro-inflammatory cytokine production by anti-inflammatory mechanisms (138–140). This evidence concerns the gene MIF and COVID-19.